Parent Educational Discharge Support Strategies
Nurse-Led Parent Educational Discharge Support Strategies (PEDSS) for Children Newly Diagnosed With Cancer
1 other identifier
interventional
289
2 countries
16
Brief Summary
After the initial hospitalization, parents of children newly diagnosed with cancer assume responsibility for assessing and managing their care; however, parents are often overwhelmed with information received throughout the hospitalization and are apprehensive about caring for their child at home. Parents want concise, focused information on how to care for their child after the hospital discharge. Two parent education discharge support strategies (PEDSS) were created to use at hospital discharge. PEDSS consists of a symptom management intervention and a support for the caregiver intervention. A cluster randomized control trial will assess the effectiveness and feasibility of the two different interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2017
Typical duration for not_applicable
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2017
CompletedFirst Posted
Study publicly available on registry
July 24, 2017
CompletedStudy Start
First participant enrolled
December 29, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 29, 2020
CompletedJune 30, 2020
June 1, 2020
2.5 years
July 17, 2017
June 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change from baseline pain severity to two months
Wong-Baker Faces Scale
At baseline and monthly for two additional months
Change from baseline fatigue severity to two months
Categorized as none to mild or moderate to severe from the Adolescent Fatigue Scale for adolescents 13-17 years of age, the Childhood Fatigue Scale for children 7-12 years of age, or the Parent Fatigue Scale to obtain proxy responses from parents of children \< 7 years of age
At baseline and monthly for two additional months
Change from baseline nausea severity to two months
Visual Analogue Scale in the form of a thermometer that rates the severity of nausea from 0-100
At baseline and monthly for two additional months
Change from baseline appetite changes to two months
Simplified Nutritional Appetite Questionnaire, 4-item asking about child's appetite and rated on a 5-point Likert Scale
At baseline and monthly for two additional months
Change from baseline sleep disturbances to two months
The Sleep Wake Scale
At baseline and monthly for two additional months
Change from baseline pain behavior to two months
PROMIS® Pediatric - Pain Behavior Short Form
At baseline and monthly for two additional months
Secondary Outcomes (6)
Change of baseline parents' perception of their ability to care for their child with a new cancer diagnosis to two months
At baseline and monthly for two additional months
Unplanned utilization of healthcare services
At one and two months from start of study
Change in baseline nutritional status to two months
At baseline and monthly for two additional months
Sepsis
At one and two months from start of study
PEDSS intervention feasibility
At baseline
- +1 more secondary outcomes
Study Arms (2)
PEDSS - symptom management
EXPERIMENTALContent for the PEDSS - symptom management includes the most commonly experienced treatment-related physical symptoms, descriptions of each symptom, strategies to reduce symptom distress, and when and how to contact the cancer care team.
PEDSS - support for the caregiver
EXPERIMENTALContent for the PEDSS - support for the caregiver includes five topics and suggestions on how caregivers can care for themselves during this time.
Interventions
All subjects will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge, which includes a list of home medications and information regarding whom to call for emergencies. The PEDSS - symptom management will be delivered prior to the initial hospital discharge. The nurse will review the symptom management worksheet verbally with the parent, then distribute the written worksheet to the parent.
All subjects will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge, which includes a list of home medications and information regarding whom to call for emergencies. The PEDSS - support for the caregiver will be delivered prior to the initial hospital discharge. The nurse will review the worksheet verbally with the parent, then distribute the written worksheet to the parent.
Eligibility Criteria
You may qualify if:
- A parent (referred to as "parent" but includes a parent or legal guardian) of a patient 3 to 17 years of age who is newly diagnosed with any type of malignant disease on an inpatient oncology unit
- Must speak English, Spanish, or Arabic
- Child will be or is receiving chemotherapy and/or radiation therapy
You may not qualify if:
- A parent of a child diagnosed with histiocytosis or any hematological disease considered non-malignant
- A parent whose child received the initial cancer diagnosis and initial cancer treatment while hospitalized on a non-oncology unit (i.e., surgical ward)
- A parent of a child who is experienced a relapse of a malignant disease
- A parent who is the primary caregiver of the child with cancer and is illiterate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Children's Health System of Texas Children's Medical Centercollaborator
- Cohen Children's Medical Centercollaborator
- Levine Children's Hospitalcollaborator
- Lurie Children's Hospital of Chicagocollaborator
- Maine Children's Cancer Program at Maine Medical Centercollaborator
- Medical University of South Carolina Children's Hospitalcollaborator
- Nationwide Children's Hospitalcollaborator
- Northwestern Medicine Central DuPage Hospitalcollaborator
- St. Jude Children's Research Hospitalcollaborator
- St. Louis Children's Hospitalcollaborator
- St. Peter's University Hospitalcollaborator
- University of Wisconsin Health American Children's Hospitalcollaborator
- West Virginia Univeristy Medicinecollaborator
- King Faisal Specialist Hospital & Research Centercollaborator
- Nicklaus Children's Hospitalcollaborator
Study Sites (16)
Nicklaus Children's Hospital
Miami, Florida, 33155, United States
Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
Northwestern Central DuPage Hospital
Winfield, Illinois, 60190, United States
Maine Children's Cancer Program at Maine Medical Center
Scarborough, Maine, 04074, United States
St. Louis Children's Hospital
St Louis, Missouri, 63110, United States
St. Peter's University Hospital
New Brunswick, New Jersey, 08901, United States
Cohen Children's Medical Center Northwell Health
New Hyde Park, New York, 11040, United States
Levine Children's Hospital
Charlotte, North Carolina, 28203, United States
Duke University Medical Center
Durham, North Carolina, 27710, United States
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Medical University of South Carolina Children's Hospital
Charleston, South Carolina, 29425, United States
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Children's Health System of Texas Children's Medical Center
Dallas, Texas, 75235, United States
West Virginia University Medicine
Morgantown, West Virginia, 26506, United States
University of Wisconsin Health American Children's Hospital
Madison, Wisconsin, 53792, United States
King Faisal Specialist Hospital and Research Centre-Riyadh
Riyadh, 12713 2796, Saudi Arabia
Study Officials
- PRINCIPAL INVESTIGATOR
Marilyn Hockenberry, PhD
Duke University
- STUDY DIRECTOR
Megan Arthur, BS
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2017
First Posted
July 24, 2017
Study Start
December 29, 2017
Primary Completion
June 29, 2020
Study Completion
June 29, 2020
Last Updated
June 30, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share
Each site PI participating in the study will receive a copy of their anonymous data upon completion of the study.